Satoh T, Moroi K
Jpn J Pharmacol. 1977 Apr;27(2):233-7. doi: 10.1254/jjp.27.233.
We examined the effects of pretreatment with phenobarbital and tricresylphosphates, TOCP and TCP, on the metabolism and toxicity of procaine in rats. A single administration of procaine at a dose of 250 mg/kg intraperitoneally to adult rats caused convulsion, however, phenobarbital (80 mg/kg intraperitoneally daily, 4 days) pretreatment protected against the toxicity or procaine. In contrast, pretreatment of rats with TOCP (10 mg/kg per os) or TCP (10 mg/kg per os) revealed a higher incidence of toxicity as compared to control rats. Mortality in procaine-treated rats was significantly decreased with phenobarbital-pretreatment and, conversely, increased with TOCP and TCP. Paralysis, convulsion and death were induced at the brain level of procaine of 0.303 +/- 0.025, 0.480 +/- 0.026 and 0.565 +/- 0.018 mumole/g brain wet weight, respectively. Toxic effects of procaine were, therefore, concluded to be due to the accumulation of the drug in the brain.
我们研究了用苯巴比妥和磷酸三甲苯酯(TOCP和TCP)预处理对大鼠体内普鲁卡因代谢及毒性的影响。给成年大鼠腹腔注射250mg/kg剂量的单次普鲁卡因会引起惊厥,然而,苯巴比妥预处理(每天腹腔注射80mg/kg,共4天)可预防普鲁卡因的毒性。相比之下,用TOCP(10mg/kg口服)或TCP(10mg/kg口服)预处理大鼠,与对照大鼠相比,毒性发生率更高。苯巴比妥预处理可显著降低普鲁卡因处理大鼠的死亡率,相反,TOCP和TCP会增加死亡率。在大脑普鲁卡因水平分别为0.303±0.025、0.480±0.026和0.565±0.018微摩尔/克脑湿重时,会分别诱发麻痹、惊厥和死亡。因此,得出结论,普鲁卡因的毒性作用是由于药物在大脑中蓄积所致。